News Roche offers free access to diabetes app to relieve pressure... Roche is offering free access to its mySugr Pro diabetes management app in the UK to relieve pressure on the NHS during the COVID-19
News Sanofi begins trial of Kevzara against COVID-19 complication... Sanofi and Regeneron are throwing an already-approved drug at COVID-19, testing Kevzara (sarilumab) in patients hospitalised with severe disease.
News UK court imposes safety rules on off-label use of Avastin in... Bayer has said a new UK court ruling could limit off-label use of Roche's Avastin in ophthalmology by imposing stricter safety and consent measures.
News Large scale tests for coronavirus 'unfeasible', says Roche C... Widespread testing for the coronavirus is still unfeasible, Roche’s CEO Severin Schwan said in a press briefing on the coronavirus outbreak from industry leaders.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.